This application is in response to PAS-03-023 International Research Collaboration on Drug Addiction. We had received an administrative supplement that added Auckland, New Zealand to our multisite Infant Development, Environment And Lifestyle (IDEAL) longitudinal study of the effects of prenatal methamphetamine (MA) exposure on child outcome. We have already established a Community Research Network (CRN) that includes four Clinical Research Partners (CRPs), from diverse study populations in Iowa, Oklahoma, California, and Hawaii where MA use by pregnant women is prevalent and where data collection for this 3-year longitudinal study is already underway. The supplement provided funds to recruit and conduct newborn and 1-month assessments of the New Zealand cohort. The purpose of this study is to extend the longitudinal follow up of the New Zealand cohort to 3 years. Recruitment in New Zealand is underway and 240 subjects with MA exposure and matched comparisons are anticipated. The longitudinal protocol of the proposed study includes annual visits at 1, 2, and 3 years and a home visit at 2.5 years. Measures of child include domains of arousal regulation, cognition, social relationships, neuromotor, neuroendocrine function, behavior problems and medical status. Measures of psychosocial risk factors include caregiving context and caregiver characteristics. We will test hypotheses related to the effects of prenatal MA exposure on child outcome when covariates including other drug use are controlled;hypotheses related to the role of psychosocial risk factors mediating effects of prenatal MA exposure on child outcome. The Auckland cohort will be analyzed separately and together with the larger IDEAL sample. With Auckland, New Zealand added to the IDEAL study as a fifth CRP, we will: (1) Increase the sample size of the IDEAL study;(2) Increase the observable effects of prenatal MA exposure on infant outcome by studying a group with less variability in the purity of MA and with a higher frequency of use than in other IDEAL sites;(3) Increase our understanding of the role of cultural childrearing and out-of-home placement issues, including social policy on the outcome of MA exposed children, and (4) Make an international contribution to our understanding of the effect of prenatal MA exposure on child outcome. The proposed study will advance our scientific understanding of this emerging problem and enhance our ability to develop appropriate interventions for these children.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA021757-05
Application #
8126469
Study Section
Child Psychopathology and Developmental Disabilities Study Section (CPDD)
Program Officer
Boyce, Cheryl A
Project Start
2007-09-05
Project End
2013-08-31
Budget Start
2011-09-01
Budget End
2013-08-31
Support Year
5
Fiscal Year
2011
Total Cost
$365,147
Indirect Cost
Name
Women and Infants Hospital-Rhode Island
Department
Type
DUNS #
069851913
City
Providence
State
RI
Country
United States
Zip Code
02905
Chakraborty, Arijit; Anstice, Nicola S; Jacobs, Robert J et al. (2017) Global motion perception is related to motor function in 4.5-year-old children born at risk of abnormal development. Vision Res 135:16-25
Chakraborty, Arijit; Anstice, Nicola S; Jacobs, Robert J et al. (2015) Global motion perception is independent from contrast sensitivity for coherent motion direction discrimination and visual acuity in 4.5-year-old children. Vision Res 115:83-91
Chakraborty, Arijit; Anstice, Nicola S; Jacobs, Robert J et al. (2015) Prenatal exposure to recreational drugs affects global motion perception in preschool children. Sci Rep 5:16921
Abar, Beau; LaGasse, Linda L; Wouldes, Trecia et al. (2014) Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment. Prev Sci 15:767-76
Wouldes, Trecia A; Lagasse, Linda L; Huestis, Marilyn A et al. (2014) Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years. Neurotoxicol Teratol 42:77-84
Wouldes, Trecia A; LaGasse, Linda L; Derauf, Chris et al. (2013) Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug Alcohol Depend 127:101-7
Galland, Barbara C; Mitchell, Ed A; Thompson, John M D et al. (2013) Auditory evoked arousal responses of 3-month-old infants exposed to methamphetamine in utero: a nap study. Acta Paediatr 102:424-30
Wu, Min; Lagasse, Linda L; Wouldes, Trecia A et al. (2013) Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States. Matern Child Health J 17:566-75
Smith, Lynne M; LaGasse, Linda L; Derauf, Chris et al. (2011) Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicol Teratol 33:176-84
LaGasse, Linda L; Wouldes, Trecia; Newman, Elana et al. (2011) Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol 33:166-75